BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 12594841)

  • 21. Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.
    Spaggiari GM; Contini P; Carosio R; Arvigo M; Ghio M; Oddone D; Dondero A; Zocchi MR; Puppo F; Indiveri F; Poggi A
    Blood; 2002 Mar; 99(5):1706-14. PubMed ID: 11861287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
    Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
    Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
    Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis.
    Yoshino T; Cao L; Nishiuchi R; Matsuo Y; Yamadori I; Kondo E; Teramoto N; Hayashi K; Takahashi K; Kamikawaji N
    Eur J Immunol; 1995 Aug; 25(8):2190-4. PubMed ID: 7545111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro refolding and functional study of soluble HLA-G1-peptide complex].
    Yang JN; Wu XW; Liang ZH; Han JY; Huang YF; Gong FL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):265-8. PubMed ID: 15862135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
    Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Stignani M; Castellazzi M; Tamborino C; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2008 May; 14(4):446-54. PubMed ID: 18208868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G
    Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo apoptosis of CD8(+) lymphocytes in acute myeloid leukemia patients: involvement of soluble HLA-I and Fas ligand.
    Contini P; Zocchi MR; Pierri I; Albarello A; Poggi A
    Leukemia; 2007 Feb; 21(2):253-60. PubMed ID: 17170722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway.
    Furuke K; Shiraishi M; Mostowski HS; Bloom ET
    J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
    Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
    J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
    Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
    J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A; Stein GM; Pfüller U; Schietzel M
    Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Killer cell inhibitory receptor interactions with HLA class I molecules: implications for alloreactivity and transplantation.
    Young NT; Bunce M; Morris PJ; Welsh KI
    Hum Immunol; 1997 Jan; 52(1):1-11. PubMed ID: 9021404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.